Teladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure

JPMorgan analyst Lisa C. Gill maintained a Neutral rating on Teladoc Health, Inc TDOC on Thursday with a price target of $9, down from the prior $11.On April 30, Teladoc reported first-quarter revenue of $629.4 million, down 3%, beating the consensus estimate of $619.29 million. The company reported a first-quarter loss of 53 cents per share, missing analyst estimates for a loss of 34 cents per share.Also Read: Teladoc Health Partners With Eli Liily’s LillyDirect to Expand Access to Zepbound For Weight Loss ...